Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of Zimmer Biomet Holdings Inc (NYSE: ZBH) closed at $89.8 in the last session, up 0.75% from day before closing price of $89.13. In other words, the price has increased by $0.75 from its previous closing price. On the day, 1.41 million shares were traded. ZBH stock price reached its highest trading level at $89.885 during the session, while it also had its lowest trading level at $88.81.
Ratios:
We take a closer look at ZBH’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 13.77 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 14.75. For the most recent quarter (mrq), Quick Ratio is recorded 1.39 and its Current Ratio is at 2.43. In the meantime, Its Debt-to-Equity ratio is 0.64 whereas as Long-Term Debt/Eq ratio is at 0.59.
On November 06, 2025, JP Morgan Downgraded its rating to Neutral which previously was Overweight but kept the price unchanged to $100.
On September 18, 2025, Rothschild & Co Redburn started tracking the stock assigning a Buy rating and target price of $130.Rothschild & Co Redburn initiated its Buy rating on September 18, 2025, with a $130 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 11 ’25 when Yi Sang sold 1,200 shares for $103.58 per share. The transaction valued at 124,302 led to the insider holds 18,584 shares of the business.
Yi Sang bought 1,200 shares of ZBH for $124,302 on Sep 11 ’25. On Sep 08 ’25, another insider, Winkler Lori, who serves as the SVP and CHRO of the company, sold 1,500 shares for $104.15 each. As a result, the insider received 156,225 and left with 6,833 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZBH now has a Market Capitalization of 17796704256 and an Enterprise Value of 24737103872. As of this moment, Zimmer’s Price-to-Earnings (P/E) ratio for their current fiscal year is 22.22, and their Forward P/E ratio for the next fiscal year is 10.56. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.38. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.22 while its Price-to-Book (P/B) ratio in mrq is 1.40. Its current Enterprise Value per Revenue stands at 3.088 whereas that against EBITDA is 9.368.
Stock Price History:
The Beta on a monthly basis for ZBH is 0.62, which has changed by -0.16933829 over the last 52 weeks, in comparison to a change of 0.13153219 over the same period for the S&P500. Over the past 52 weeks, ZBH has reached a high of $114.44, while it has fallen to a 52-week low of $85.33. The 50-Day Moving Average of the stock is -5.27%, while the 200-Day Moving Average is calculated to be -8.52%.
Shares Statistics:
According to the various share statistics, ZBH traded on average about 1.95M shares per day over the past 3-months and 2648980 shares per day over the past 10 days. A total of 198.20M shares are outstanding, with a floating share count of 197.91M. Insiders hold about 0.14% of the company’s shares, while institutions hold 99.76% stake in the company. Shares short for ZBH as of 1764288000 were 8496861 with a Short Ratio of 4.36, compared to 1761868800 on 7273875. Therefore, it implies a Short% of Shares Outstanding of 8496861 and a Short% of Float of 4.9200002.
Dividends & Splits
The forward annual dividend rate for ZBH is 0.96, which was 0.96 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.010770785. The stock’s 5-year Average Dividend Yield is 0.8. The current Payout Ratio is 21.66% for ZBH, which recently paid a dividend on 2025-09-30 with an ex-dividend date of 2025-12-30. Stock splits for the company last occurred on 2022-03-01 when the company split stock in a 103:100 ratio.
Earnings Estimates
The firm’s stock currently is rated by 25.0 analysts. The consensus estimate for the next quarter is $1.92, with high estimates of $2.09 and low estimates of $1.78.
Analysts are recommending an EPS of between $8.23 and $8.11 for the fiscal current year, implying an average EPS of $8.17. EPS for the following year is $8.5, with 27.0 analysts recommending between $8.98 and $8.26.
Revenue Estimates
According to 23 analysts,. The current quarter’s revenue is expected to be $2.22B. It ranges from a high estimate of $2.24B to a low estimate of $2.2B. As of. The current estimate, Zimmer Biomet Holdings Inc’s year-ago sales were $2.02BFor the next quarter, 23 analysts are estimating revenue of $2.07B. There is a high estimate of $2.12B for the next quarter, whereas the lowest estimate is $1.99B.
A total of 26 analysts have provided revenue estimates for ZBH’s current fiscal year. The highest revenue estimate was $8.23B, while the lowest revenue estimate was $8.16B, resulting in an average revenue estimate of $8.21B. In the same quarter a year ago, actual revenue was $7.68BBased on 25 analysts’ estimates, the company’s revenue will be $8.63B in the next fiscal year. The high estimate is $8.75B and the low estimate is $8.34B.
